236 related articles for article (PubMed ID: 8429821)
1. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
Yasuda RP; Ciesla W; Flores LR; Wall SJ; Li M; Satkus SA; Weisstein JS; Spagnola BV; Wolfe BB
Mol Pharmacol; 1993 Feb; 43(2):149-57. PubMed ID: 8429821
[TBL] [Abstract][Full Text] [Related]
2. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines.
Wall SJ; Yasuda RP; Li M; Wolfe BB
Mol Pharmacol; 1991 Nov; 40(5):783-9. PubMed ID: 1944243
[TBL] [Abstract][Full Text] [Related]
3. Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.
Li M; Yasuda RP; Wall SJ; Wellstein A; Wolfe BB
Mol Pharmacol; 1991 Jul; 40(1):28-35. PubMed ID: 1857338
[TBL] [Abstract][Full Text] [Related]
4. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
Wall SJ; Yasuda RP; Hory F; Flagg S; Martin BM; Ginns EI; Wolfe BB
Mol Pharmacol; 1991 May; 39(5):643-9. PubMed ID: 2034236
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB
Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425
[TBL] [Abstract][Full Text] [Related]
6. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
Lazareno S; Buckley NJ; Roberts FF
Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
[TBL] [Abstract][Full Text] [Related]
7. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
[TBL] [Abstract][Full Text] [Related]
8. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD
Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of subtypes m1-m5 of muscarinic receptors in forebrain by chronic atropine administration.
Wall SJ; Yasuda RP; Li M; Ciesla W; Wolfe BB
J Pharmacol Exp Ther; 1992 Aug; 262(2):584-8. PubMed ID: 1323653
[TBL] [Abstract][Full Text] [Related]
10. Subtype-specific antibodies for muscarinic cholinergic receptors. I. Characterization using transfected cells and avian and mammalian cardiac membranes.
Mayanil CS; Richardson RM; Hosey MM
Mol Pharmacol; 1991 Dec; 40(6):900-7. PubMed ID: 1758441
[TBL] [Abstract][Full Text] [Related]
11. Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man.
Ryberg AT; Warfvinge G; Axelsson L; Soukup O; Götrick B; Tobin G
Arch Oral Biol; 2008 Jan; 53(1):66-74. PubMed ID: 17825245
[TBL] [Abstract][Full Text] [Related]
12. Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues.
Dörje F; Levey AI; Brann MR
Mol Pharmacol; 1991 Oct; 40(4):459-62. PubMed ID: 1921982
[TBL] [Abstract][Full Text] [Related]
13. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
Olianas MC; Ingianni A; Maullu C; Adem A; Karlsson E; Onali P
J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767
[TBL] [Abstract][Full Text] [Related]
14. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
Buckley NJ; Bonner TI; Buckley CM; Brann MR
Mol Pharmacol; 1989 Apr; 35(4):469-76. PubMed ID: 2704370
[TBL] [Abstract][Full Text] [Related]
15. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
Lazareno S; Dolezal V; Popham A; Birdsall NJ
Mol Pharmacol; 2004 Jan; 65(1):257-66. PubMed ID: 14722259
[TBL] [Abstract][Full Text] [Related]
16. Human skin fibroblasts express m2, m4, and m5 subtypes of muscarinic acetylcholine receptors.
Buchli R; Ndoye A; Rodriguez JG; Zia S; Webber RJ; Grando SA
J Cell Biochem; 1999 Aug; 74(2):264-77. PubMed ID: 10404395
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation.
Gil DW; Krauss HA; Bogardus AM; WoldeMussie E
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1434-42. PubMed ID: 9191607
[TBL] [Abstract][Full Text] [Related]
18. Expression of functional muscarinic acetylcholine receptor subtypes in human corpus cavernosum and in cultured smooth muscle cells.
Traish AM; Palmer MS; Goldstein I; Moreland RB
Receptor; 1995; 5(3):159-76. PubMed ID: 8729195
[TBL] [Abstract][Full Text] [Related]
19. Ligand binding properties of muscarinic acetylcholine receptor subtypes (m1-m5) expressed in baculovirus-infected insect cells.
Dong GZ; Kameyama K; Rinken A; Haga T
J Pharmacol Exp Ther; 1995 Jul; 274(1):378-84. PubMed ID: 7616422
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
